New acquisition has goal of developing laser-based cancer proton therapy system
Proton therapy systems developer HIL Applied Medical (Jerusalem, Israel) has acquired Nanolabz (Reno, NV), which develops and fabricates smart targets for laser-based proton acceleration. HIL Applied Medical is developing a new class of ultra-compact, high-performance proton beam therapy systems for cancer based on high-intensity lasers and nano-engineered smart targetry.
Related: Terawatt laser enables higher energies for particle acceleration in cancer therapy
A proton beam is a form of focused radiation used to treat solid tumors. When compared to traditional radiation therapy (x-ray or photons), it reduces damage to surrounding healthy tissue by 2-6X, thereby reducing toxicities and improving patient survival and quality of life. Proton therapy is used routinely for treating many types of cancer—it is FDA-cleared and reimbursed by both federal and private insurers.
For more information, please visit www.hilappliedmedical.com.
BioOptics World Editors
We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)